|
US2859239A
(en)
*
|
1956-08-17 |
1958-11-04 |
Dow Chemical Co |
Acrylic acid compounds
|
|
CH549339A
(de)
|
1971-05-12 |
1974-05-31 |
Ciba Geigy Ag |
Herbizides mittel.
|
|
US5763647A
(en)
*
|
1990-03-30 |
1998-06-09 |
Shionogi & Co., Ltd. |
Preparation of optically active 1,4-bridged-cyclohexane carboxylic acid derivatives
|
|
EP0520419A3
(en)
*
|
1991-06-26 |
1993-06-16 |
Union Carbide Chemicals & Plastics Technology Corporation |
Production of unsaturated cycloaliphatic esters and derivatives thereof
|
|
AU1507199A
(en)
|
1997-12-15 |
1999-07-05 |
Yamanouchi Pharmaceutical Co., Ltd. |
Novel pyrimidine-5-carboxamide derivatives
|
|
DE69933680T2
(de)
|
1998-08-29 |
2007-08-23 |
Astrazeneca Ab |
Pyrimidine verbindungen
|
|
AU5107900A
(en)
|
1999-06-09 |
2000-12-28 |
Yamanouchi Pharmaceutical Co., Ltd. |
Novel heterocyclic carboxamide derivatives
|
|
AU5108000A
(en)
|
1999-06-10 |
2001-01-02 |
Yamanouchi Pharmaceutical Co., Ltd. |
Novel nitrogen-contaiing heterocyclic derivatives or salts thereof
|
|
AU5636900A
(en)
|
1999-06-30 |
2001-01-31 |
Merck & Co., Inc. |
Src kinase inhibitor compounds
|
|
HK1045507A1
(zh)
|
1999-08-12 |
2002-11-29 |
Vertex Pharmaceuticals Incorporated |
C-jun n-末端激酶(jnk)及其他蛋白质激酶的抑制物
|
|
TWI329105B
(en)
|
2002-02-01 |
2010-08-21 |
Rigel Pharmaceuticals Inc |
2,4-pyrimidinediamine compounds and their uses
|
|
GB0206215D0
(en)
|
2002-03-15 |
2002-05-01 |
Novartis Ag |
Organic compounds
|
|
AU2003220968A1
(en)
|
2002-03-28 |
2003-10-13 |
Kyowa Hakko Kogyo Co., Ltd. |
Anti-inflammatory agent
|
|
EP1518855B1
(en)
|
2002-06-28 |
2011-10-26 |
Astellas Pharma Inc. |
Diaminopyrimidinecarboxa mide derivative
|
|
BR0313059B8
(pt)
|
2002-07-29 |
2021-07-27 |
Rigel Pharmaceuticals |
composto, e, composição farmacêutica
|
|
WO2004054617A1
(ja)
|
2002-12-13 |
2004-07-01 |
Kyowa Hakko Kogyo Co., Ltd. |
中枢疾患の予防および／または治療剤
|
|
WO2004063141A1
(ja)
*
|
2003-01-16 |
2004-07-29 |
Toray Fine Chemicals Co,. Ltd. |
光学活性ジアシル酒石酸の回収方法
|
|
MXPA05007503A
(es)
|
2003-01-17 |
2005-09-21 |
Warner Lambert Co |
Heterociclicos 2-aminopiridina sustituidos como inhibidores de proliferacion celular.
|
|
DE602004022633D1
(de)
|
2003-01-30 |
2009-10-01 |
Boehringer Ingelheim Pharma |
2,4-diaminopyrimidinderivate, die sich als inhibitoren von pkc-theta eignen
|
|
TWI378923B
(en)
|
2003-08-15 |
2012-12-11 |
Novartis Ag |
Pyrimidine derivatives
|
|
CN1871009A
(zh)
|
2003-09-24 |
2006-11-29 |
惠氏控股公司 |
作为抗癌剂的5－芳基嘧啶
|
|
WO2005095382A1
(ja)
|
2004-03-30 |
2005-10-13 |
Kyowa Hakko Kogyo Co., Ltd. |
抗腫瘍剤
|
|
WO2006014482A1
(en)
|
2004-07-08 |
2006-02-09 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Pyrimidine derivatives useful as inhibitors of pkc-theta
|
|
EP1796679A1
(en)
|
2004-09-10 |
2007-06-20 |
Altana Pharma AG |
Ciclesonide and syk inhibitor combination and methods of use thereof
|
|
JP2008512429A
(ja)
|
2004-09-10 |
2008-04-24 |
ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング |
ロフルミラストとｓｙｋインヒビターとの組合せ物並びにその使用方法
|
|
JP2006124387A
(ja)
|
2004-09-30 |
2006-05-18 |
Taisho Pharmaceut Co Ltd |
新規なキノリン、テトラヒドロキナゾリン、及びピリミジン誘導体と、これらを使用することに関連した治療方法
|
|
RU2410379C2
(ru)
|
2004-09-30 |
2011-01-27 |
Тиботек Фармасьютикалз Лтд. |
5-замещенные пиримидины, ингибирующие вич
|
|
WO2006091737A1
(en)
|
2005-02-24 |
2006-08-31 |
Kemia, Inc. |
Modulators of gsk-3 activity
|
|
WO2006099231A1
(en)
|
2005-03-10 |
2006-09-21 |
Bayer Pharmaceuticals Corporation |
Pyrimidine derivatives for treatment of hyperproliferative disorders
|
|
WO2007032445A1
(ja)
|
2005-09-16 |
2007-03-22 |
Kyowa Hakko Kogyo Co., Ltd. |
タンパク質キナーゼ阻害剤
|
|
CA2657260A1
(en)
|
2006-07-21 |
2008-01-24 |
Novartis Ag |
2, 4 -di (arylaminio) -pyrimidine-5-carboxamide compounds as jak kinases inhibitors
|
|
US8188113B2
(en)
|
2006-09-14 |
2012-05-29 |
Deciphera Pharmaceuticals, Inc. |
Dihydropyridopyrimidinyl, dihydronaphthyidinyl and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
|
|
US20080139531A1
(en)
|
2006-12-04 |
2008-06-12 |
Alcon Manufacturing Ltd. |
Use of connective tissue mast cell stabilizers to facilitate ocular surface re-epithelization and wound repair
|
|
CL2007003693A1
(es)
*
|
2006-12-22 |
2008-06-27 |
Actelion Pharmaceuticals Ltd |
Compuestos derivados de pirido [3,2-b] [1,4] tiazina; composicion farmaceutica que contiene dichos compuestos; y su uso en el tratamiento de infecciones bacterianas.
|
|
AP2009005010A0
(en)
|
2007-04-18 |
2009-10-31 |
Pfizer Prod Inc |
Sulfonyl amide derivatives for the treatment of abnormal cell growth
|
|
US20090036440A1
(en)
|
2007-04-27 |
2009-02-05 |
Astrazeneca Ab |
Novel pyrimidine derivatives - 816
|
|
WO2009010789A2
(en)
|
2007-07-16 |
2009-01-22 |
Astrazeneca Ab |
Pyrimidine derivatives 934
|
|
CN101903357A
(zh)
|
2007-07-17 |
2010-12-01 |
里格尔药品股份有限公司 |
作为pkc抑制剂的环状胺取代的嘧啶二胺
|
|
JP5269444B2
(ja)
*
|
2008-03-11 |
2013-08-21 |
東ソー・ファインケム株式会社 |
固体ルイス酸触媒、それを用いたディールスアルダー付加物の製造方法
|
|
KR20100132550A
(ko)
|
2008-04-16 |
2010-12-17 |
포톨라 파마슈티컬스, 인코포레이티드 |
ｓｙｋ 또는 ＪＡＫ 키나제 억제제로서의 ２,６－디아미노-피리미딘－５－일－카르복스아미드
|
|
JP5705720B2
(ja)
|
2008-04-16 |
2015-04-22 |
ポートラ ファーマシューティカルズ， インコーポレイテッド |
Ｓｙｋまたはｊａｋキナーゼ阻害剤としての２，６−ジアミノ−ピリミジン−５−イル−カルボキサミド
|
|
JP2011518219A
(ja)
|
2008-04-22 |
2011-06-23 |
ポートラ ファーマシューティカルズ， インコーポレイテッド |
タンパク質キナーゼの阻害剤
|
|
JP5302389B2
(ja)
|
2008-04-29 |
2013-10-02 |
エフ．ホフマン−ラ ロシュ アーゲー |
Ｊｎｋのピリミジニルピリドンインヒビター
|
|
EP2300013B2
(en)
|
2008-05-21 |
2024-11-13 |
Takeda Pharmaceutical Company Limited |
Phosphorous derivatives as kinase inhibitors
|
|
UY31929A
(es)
|
2008-06-25 |
2010-01-05 |
Irm Llc |
Compuestos y composiciones como inhibidores de cinasa
|
|
NZ603525A
(en)
|
2008-06-27 |
2015-02-27 |
Celgene Avilomics Res Inc |
Pyrimidine based compound and uses thereof
|
|
US8338439B2
(en)
|
2008-06-27 |
2012-12-25 |
Celgene Avilomics Research, Inc. |
2,4-disubstituted pyrimidines useful as kinase inhibitors
|
|
WO2010024430A1
(ja)
|
2008-09-01 |
2010-03-04 |
アステラス製薬株式会社 |
2,4-ジアミノピリミジン化合物
|
|
EP2159220A1
(en)
*
|
2008-09-02 |
2010-03-03 |
Nabriva Therapeutics AG |
Organic compounds
|
|
TWI453207B
(zh)
*
|
2008-09-08 |
2014-09-21 |
Signal Pharm Llc |
胺基三唑并吡啶，其組合物及使用其之治療方法
|
|
CA2737738A1
(en)
|
2008-09-18 |
2010-03-25 |
Astellas Pharma Inc. |
Heterocyclic carboxamide compounds
|
|
TW201016676A
(en)
|
2008-10-03 |
2010-05-01 |
Astrazeneca Ab |
Heterocyclic derivatives and methods of use thereof
|
|
CN102272291B
(zh)
|
2008-10-31 |
2018-01-16 |
詹森生物科技公司 |
人胚胎干细胞向胰腺内分泌谱系的分化
|
|
US8513242B2
(en)
|
2008-12-12 |
2013-08-20 |
Cystic Fibrosis Foundation Therapeutics, Inc. |
Pyrimidine compounds and methods of making and using same
|
|
EP2375899B1
(en)
|
2009-01-12 |
2015-02-25 |
Array Biopharma Inc. |
Piperidine-containing compounds and use thereof in the treatment of diabetes
|
|
MX2011007499A
(es)
|
2009-01-13 |
2011-08-04 |
Glaxo Group Ltd |
Derivados de pirimidin-carboxamida como inhibidores de la cinasa syk.
|
|
ES2635504T3
(es)
|
2009-01-21 |
2017-10-04 |
Rigel Pharmaceuticals, Inc. |
Derivados de N2-(3-piridilo o fenil)-N4-(4-piperidil)-2,4-pirimidinadiamina útiles en el tratamiento de enfermedades inflamatorias, toimmunitarias o proliferativas
|
|
US8367689B2
(en)
|
2009-05-06 |
2013-02-05 |
Portola Pharmaceuticals, Inc. |
Inhibitors of JAK
|
|
JP5364159B2
(ja)
|
2009-05-08 |
2013-12-11 |
アステラス製薬株式会社 |
ジアミノへテロ環カルボキサミド化合物
|
|
JP2012148977A
(ja)
|
2009-05-20 |
2012-08-09 |
Astellas Pharma Inc |
アミノシクロヘキシルアルキル基を有する２，４−ジアミノピリミジン化合物
|
|
CN102498110A
(zh)
|
2009-06-10 |
2012-06-13 |
雅培制药有限公司 |
作为激酶抑制剂的2-(lh-吡唑-4-基氨基)-嘧啶
|
|
JP2012197231A
(ja)
|
2009-08-06 |
2012-10-18 |
Oncotherapy Science Ltd |
Ｔｔｋ阻害作用を有するピリジンおよびピリミジン誘導体
|
|
WO2011065800A2
(ko)
|
2009-11-30 |
2011-06-03 |
주식회사 오스코텍 |
피리미딘 유도체, 이의 제조방법 및 이를 함유하는 약학적 조성물
|
|
US20110130415A1
(en)
|
2009-12-01 |
2011-06-02 |
Rajinder Singh |
Protein kinase c inhibitors and uses thereof
|
|
US20130172562A1
(en)
*
|
2010-06-17 |
2013-07-04 |
Dr. Reddy's Laboratories, Inc. |
Process for the preparation of a single enantiomer of 3-aminopiperidine dihydrochloride
|
|
JP6035238B2
(ja)
|
2010-07-21 |
2016-11-30 |
ライジェル ファーマシューティカルズ， インコーポレイテッド |
プロテインキナーゼｃ阻害剤およびその使用
|
|
US8580805B2
(en)
|
2010-08-31 |
2013-11-12 |
Hubert Maehr |
Pyrimidine carboxamide derivatives
|
|
WO2012045010A1
(en)
|
2010-09-30 |
2012-04-05 |
Portola Pharmaceuticals, Inc. |
Combinations of 4-(3-(2h-1,2,3-triazo-2-yl) phenylamino)-2-((1r,2s)-2-aminocyclohexylamino) pyrimidine-5-carboxamide and fludarabine
|
|
WO2012044936A1
(en)
|
2010-09-30 |
2012-04-05 |
Portola Pharmaceuticals, Inc. |
Combination therapy with 4-(3-(2h-1,2,3-triazol-2-yl)phenylamino)-2-((1r,2s)-2-aminocyclohexylamino)pyrimidine-5-carboxamide
|
|
HRP20240097T1
(hr)
|
2011-04-22 |
2024-03-29 |
Signal Pharmaceuticals, Llc |
Supstituirani diaminokarboksamid i diaminokarbonitril pirimidini, njihovi pripravci i postupci liječenja s njima
|
|
WO2014019166A1
(zh)
*
|
2012-08-01 |
2014-02-06 |
上海威智医药科技有限公司 |
高活性硼烷类化合物的工业化生产方法
|
|
JP2014031327A
(ja)
*
|
2012-08-02 |
2014-02-20 |
Kaneka Corp |
光学活性シス−２−アミノ−シクロヘキサンカルボン酸誘導体およびその前駆体の製造法
|
|
AR099376A1
(es)
|
2013-12-20 |
2016-07-20 |
Signal Pharm Llc |
Compuestos de diaminopirimidilo sustituidos, sus composiciones y métodos de tratamiento con aquellos
|
|
NZ715903A
(en)
*
|
2014-01-30 |
2017-06-30 |
Signal Pharm Llc |
Solid forms of 2-(tert-butylamino)-4-((1r,3r,4r)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide, compositions thereof and methods of their use
|
|
TWI523838B
(zh)
*
|
2014-03-21 |
2016-03-01 |
Far Eastern New Century Corp |
Terephthalic acid and 4-methyl-3-cyclohexene-1-carboxylic acid Ester preparation method
|
|
KR20230035424A
(ko)
|
2014-10-06 |
2023-03-13 |
시그날 파마소티칼 엘엘씨 |
치환된 아미노퓨린 화합물, 그의 조성물 및 그를 사용한 치료 방법
|
|
EP3233808B1
(en)
|
2014-12-16 |
2021-07-14 |
Signal Pharmaceuticals, LLC |
Medical uses comprising methods for measurement of inhibition of c-jun n-terminal kinase in skin
|
|
WO2016100310A1
(en)
|
2014-12-16 |
2016-06-23 |
Signal Pharmaceuticals, Llc |
Formulations of 2-(tert-butylamino)-4-((1r,3r,4r)-3-hydroxy-4-methycyclohexylamino)-pyrimidine-5-carboxamide
|
|
CA2975260C
(en)
|
2015-01-29 |
2024-05-21 |
Signal Pharmaceuticals Llc |
Isotopologues of 2-(tert-butylamino)-4-((1r,3r,4r)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide
|
|
ES2994877T3
(en)
*
|
2015-07-24 |
2025-02-03 |
Celgene Corp |
Methods of synthesis of (1r,2r,5r)-5-amino-2-methylcyclohexanol hydrochloride and intermediates useful therein
|